CPH.TO CIPHER PHARMACEUTICALS INC
$14.30▲ +0.70%
Healthcare
Other
Volume 18.6K
Avg Volume (10D) 30.0K
Key Metrics & Fundamentals
Market Cap
$363.44M
P/E Ratio
9.3
Div Yield
–%
52W Range
12.48 - 20.56
% vs 50 MA
-9.73%
% vs 200 MA
-11.27%
RSI-14
40.1
MACD Histogram
+0.0900
Beta (1Y vs SPY)
0.12
Free Cash Flow
$3.96M
Gross Rev
$12.51M
Gross Profit
$10.30M
EBITDA
$7.40M
COGS
$2.21M
Operating Exp
$4.70M
Operating Income
$5.60M
EBIT
$5.60M
Pretax Income
$4.95M
Net Income
$6.16M
EPS (Diluted)
0.24
Price & Volume History
Loading chart…
Recent News
Cipher Pharmaceuticals' Ownership Of Certain Abscoria-Related Clinical Data Affirmed by US Court
MT Newswires · Sep 1, 2026 9:23 PM

Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
CNW Group · Sep 1, 2026 9:00 PM
Cipher Pharmaceuticals Inc (CPHRF) (Q2 2026) Earnings Call Highlights: Epuris Growth and ...
GuruFocus.com · Aug 12, 2026 11:02 PM

Cipher Pharmaceuticals Q2 Earnings Call Highlights
MarketBeat · Aug 12, 2026 8:04 PM

Cipher Pharmaceuticals Reports Second Quarter 2026 Results
CNW Group · Aug 11, 2026 9:00 PM
Cipher Pharmaceuticals Schedules Q2 2026 Earnings Release and Conference Call
CNW Group · Jul 31, 2026 6:31 PM
Cipher Pharmaceuticals Inks LOI With pCPA to List Severe Acne Treatment Epuris
MT Newswires · Jul 7, 2026 11:42 AM
Cipher Pharmaceuticals and the pan-Canadian Pharmaceutical Alliance (pCPA) Sign Letter of Intent for Public Drug Plan Coverage of Epuris®
CNW Group · Jul 6, 2026 9:41 PM
Cipher Pharmaceuticals Announces Results of Annual General Meeting of Shareholders
CNW Group · Jun 18, 2026 5:00 PM
Financial Overview - Income Statement
Quarterly
Mar 2026
See CPH.TO's money flow as a full page
Social Sentiment
No Reddit posts found for CPH.TO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.